A Simple Paper-Based, Wearable Device for Long Term Sweat Analysis
|
By LabMedica International staff writers Posted on 16 Jun 2020 |

Image: The evaporation of sweat on paper pads could be used for fluid transport in a wearable device over long periods of time. The resulting dry layer of caked salts would preserve a `time-stamped` record of biomarkers of interest (Photo courtesy of Dr. Orlin D. Velev and co-authors, North Carolina State University)
By cleverly manipulating paper geometry, researchers created a paper-based wearable device to collect, transport, and analyze sweat for an extended period.
Sweat can be used to obtain an exact measurement of concentrations of medications in the blood. Furthermore, the concentrations of stress biomarkers (hormones and neurotransmitters) in bodily fluids such as sweat predict the physical and mental state of the individual.
A major problem that has so far restricted the use of wearable paper-based sweat sensors is that sweat contains salt, which, upon evaporation, becomes deposited on the device and interferes with fluid flow. To solve this problem, investigators at North Carolina State University (Raleigh, USA) characterized and analyzed how capillary action and evaporation could cooperatively be used to transport and process a sweat-like fluid containing dissolved salts and model analytes.
The investigators postulated that the joint action of capillary wicking and evaporation would sustain continuous and long-term withdrawal of the sweat-like fluid. In the laboratory they then demonstrated that paper strips of controlled geometry could passively pump fluid for sensing purposes for long duration. Thus, non-invasive osmotic extraction combined with paper microfluidics and evaporative disposal enabled sweat collection and monitoring for periods exceeding 10 days. Since the process was driven by the liquid wicking through paper, the device did not require an external power source.
The investigators also demonstrated that the salt film deposited at the evaporation pad would eventually lead to cessation of the process but at the same time would preserve a record of analytes that could be used for long-term biomarker monitoring in sweat.
"We expected that the flow of the model sweat will be suppressed by the deposition of a salt layer inside the drying pad," said senior author Dr. Orlin Velev, professor of chemical and biomolecular engineering at North Carolina State University. "By following the flow of model sweat, we found, quite surprisingly, that such a simple paper construct can achieve continuous sweat pumping and disposal for very long periods."
The wearable device for sweat analysis was described in the June 9, 2020, online edition of the journal Biomicrofluidics.
Related Links:
North Carolina State University
Sweat can be used to obtain an exact measurement of concentrations of medications in the blood. Furthermore, the concentrations of stress biomarkers (hormones and neurotransmitters) in bodily fluids such as sweat predict the physical and mental state of the individual.
A major problem that has so far restricted the use of wearable paper-based sweat sensors is that sweat contains salt, which, upon evaporation, becomes deposited on the device and interferes with fluid flow. To solve this problem, investigators at North Carolina State University (Raleigh, USA) characterized and analyzed how capillary action and evaporation could cooperatively be used to transport and process a sweat-like fluid containing dissolved salts and model analytes.
The investigators postulated that the joint action of capillary wicking and evaporation would sustain continuous and long-term withdrawal of the sweat-like fluid. In the laboratory they then demonstrated that paper strips of controlled geometry could passively pump fluid for sensing purposes for long duration. Thus, non-invasive osmotic extraction combined with paper microfluidics and evaporative disposal enabled sweat collection and monitoring for periods exceeding 10 days. Since the process was driven by the liquid wicking through paper, the device did not require an external power source.
The investigators also demonstrated that the salt film deposited at the evaporation pad would eventually lead to cessation of the process but at the same time would preserve a record of analytes that could be used for long-term biomarker monitoring in sweat.
"We expected that the flow of the model sweat will be suppressed by the deposition of a salt layer inside the drying pad," said senior author Dr. Orlin Velev, professor of chemical and biomolecular engineering at North Carolina State University. "By following the flow of model sweat, we found, quite surprisingly, that such a simple paper construct can achieve continuous sweat pumping and disposal for very long periods."
The wearable device for sweat analysis was described in the June 9, 2020, online edition of the journal Biomicrofluidics.
Related Links:
North Carolina State University
Latest Molecular Diagnostics News
- Blood-Based Biomarker Panel Outperforms Existing Liver Disease Tests
- Fully Automated Test Advances Hepatitis D Diagnosis and Monitoring
- HPV Assay Gains Expanded CE Mark for Self-Collected Vaginal Samples
- Blood Test Achieves Improved Detection of Advanced Precancerous Colorectal Lesions
- Community-Based Genetic Screening Reaches Rural and Vulnerable Populations
- Blood and Urine Liquid Biopsy Detects Early Colorectal Cancer Mutations
- Epigenetic Profiling Could Refine Prognosis in Acute Myeloid Leukemia
- Genetic Risk Score Supports Diagnosis and Prognosis in Idiopathic Pulmonary Fibrosis
- AI Reveals Immune Response Biomarkers Linked to Ebola Survival
- Extracellular Vesicle Marker Identifies Early Lung Adenocarcinoma and Predicts Recurrence
- WHO Adds First Bundibugyo Ebola Molecular Test to Emergency Use Listing
- Blood Test Helps Guide Post-Surgical Treatment in Metastatic Colorectal Cancer
- Study Supports Earlier Genetic Testing for Hereditary Breast and Ovarian Cancer
- Noninvasive Biomarkers Advance Colorectal Cancer Risk Assessment
- Rapid Brush Biopsy Test Detects Oral Cancer in One Hour
- AI-Driven Blood Test Enhances Early Detection of Multiple Cancers
Channels
Clinical Chemistry
view channel
New Machine-Learning Equation Improves LDL Cholesterol Assessment
Accurate assessment of low-density lipoprotein (LDL) cholesterol is central to cardiovascular risk management, yet calculation methods can underestimate values in some patients. Laboratories widely use... Read more
Blood Biomarker May Signal Cognitive Decline Risk a Decade Before Symptoms
Accurately identifying which cognitively healthy older adults will later develop impairment due to Alzheimer’s disease remains difficult, as brain scans and genetic testing provide only part of the risk picture.... Read moreHematology
view channel
New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more
AI Decision Support System Guides Treatment Selection for Complex Blood Cancers
Treatment selection for hematologic malignancies often requires clinicians to synthesize clinical histories, genomic alterations, prior therapies, and rapidly evolving drug options. These complex decisions... Read moreImmunology
view channel
Cell-Free Assay Detects Functional IgE for Food Allergy Diagnosis
Accurately distinguishing sensitization from clinically relevant food allergy remains a challenge for laboratories, as routine blood tests detect allergen-specific immunoglobulin E (IgE) but not its capacity... Read more
Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19
Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more
Anti-Lipid Antibody Biomarkers May Identify Early Lyme Disease and Persistent Symptoms
Lyme disease is often missed during its earliest and most treatable stage, while current serologic assays cannot distinguish active infection from prior exposure. Nearly half a million Americans are diagnosed... Read moreMicrobiology
view channel
Syndromic GI Panel Detects Cyclospora for Rapid Case Confirmation
U.S. health authorities have reported a rapid increase in cyclosporiasis since May 2026, with more than 1,600 confirmed infections and thousands of additional suspected cases under investigation.... Read more
Rapid Panel Identifies Gram-Negative Pathogens and Resistance Markers in Bloodstream Infections
Bloodstream infections require rapid identification of causative pathogens and resistance mechanisms to guide effective therapy. Delays in profiling gram-negative organisms, which are frequently associated... Read morePathology
view channel
Imaging Platform Maps Lipid Accumulations in Fabry Heart Tissue
Mapping the spatial distribution of disease-relevant molecules within tissue remains a diagnostic challenge, particularly before alterations are visible by conventional microscopy. In Fabry disease, a... Read more
AI Tissue Imaging Helps Guide Targeted Therapy for Lung Cancer
Lung cancer is the leading cause of cancer-related death, and many patients require rapid genotyping to guide targeted therapy selection. Current workflows often rely on molecular tests that are costly,... Read moreTechnology
view channel
Training Device Improves Accuracy of Pooled Molecular Diagnostics
High-throughput molecular diagnostics have transformed infectious disease detection, but many workflows remain difficult to execute accurately without extensive training. Sample pooling can cut per‑test... Read more
New CE-Certified Software Advances Whole-Genome Cancer Testing
European hospitals are increasingly using comprehensive tumor genomics to guide therapy, but routine whole genome sequencing (WGS) requires validated, regulation-compliant workflows. A newly CE-certified... Read more
National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise... Read moreIndustry
view channel
Leica Biosystems to Expand Pathology Portfolio Through StatLab Acquisition
Leica Biosystems, an operating company of Danaher, has entered into a definitive agreement to acquire privately held StatLab Medical Products from Linden Capital Partners and Audax Private Equity.... Read more








